Case Report of Graves' Disease in a 45-Year-Old Woman Secondary to Herceptin Treatment for Breast Cancer
Monoclonal Antibodies in Immunodiagnosis & Immunotherapy · 2023-12 · 42 (6) · 194-202
DOI: 10.1089/mab.2023.0011 ↗Kurz gefasst
Fallbericht in der Zeitschrift Monoclonal Antibodies in Immunodiagnosis & Immunotherapy, online erschienen am 29.12.2023. Verfasst von Chinmeri U Achonu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Clinical Sciences, Lagos University Teaching Hospital, Lagos, Nigeria. Hauptthemen laut MEDLINE: Breast Neoplasms, Graves Disease, Myxedema. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben.
Abstract (Originalsprache)
Graves' disease is the most common cause of thyrotoxicosis and is characterized by ophthalmopathy with proptosis, chemosis, or conjunctival injection; pretibial myxedema; and thyroid acropachy. It is an autoimmune disease that can be genetic or influenced by coexisting environmental factors such as exposure to anticancer drugs, including immune checkpoint inhibitors. The incidence rate of breast cancer is increasing due to rising awareness of risk factors and screening for breast cancer, and the mortality rate is decreasing due to recent advances in cancer treatment. However, there are side effects that are attributed to these treatment modalities, manifesting in various forms in breast cancer survivors, which are reflected in the patient in this case study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Clinical Sciences, Lagos University Teaching Hospital, Lagos, Nigeria.
- Department of Medicine, Endocrinology, College of Medicine, University of Lagos, Lagos, Nigeria.
- Department of Medicine, Federal Teaching Hospital Katsina, Katsina, Nigeria.
- Department of Radiodiagnosis, Lagos University Teaching Hospital, Lagos, Nigeria.
ORCID-Profile: Chinmeri U Achonu
Zitieren
APA
Achonu, C. U., Olopade, O. B., Yusuf, B. O., Fadeyi, A. A., & Fasanmade, O. A. (2023). Case Report of Graves' Disease in a 45-Year-Old Woman Secondary to Herceptin Treatment for Breast Cancer. Monoclonal Antibodies in Immunodiagnosis & Immunotherapy, 42(6), 194-202. https://doi.org/10.1089/mab.2023.0011
Vancouver
Achonu CU, Olopade OB, Yusuf BO, Fadeyi AA, Fasanmade OA. Case Report of Graves' Disease in a 45-Year-Old Woman Secondary to Herceptin Treatment for Breast Cancer. Monoclonal Antibodies in Immunodiagnosis & Immunotherapy. 2023;42(6):194-202. doi:10.1089/mab.2023.0011
BibTeX
@article{Achonu2023,
author = {Achonu, Chinmeri U and Olopade, Oluwarotimi B and Yusuf, Bashir O and Fadeyi, Abimbola A and Fasanmade, Olufemi A},
title = {Case Report of Graves' Disease in a 45-Year-Old Woman Secondary to Herceptin Treatment for Breast Cancer},
journal = {Monoclonal Antibodies in Immunodiagnosis & Immunotherapy},
year = {2023},
volume = {42},
number = {6},
pages = {194--202},
doi = {10.1089/mab.2023.0011}
}
EUVIMED